Award
NIH Reporter #75N93022C00041-P00004-9999-1
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)
Recipient
UNIVERSITY OF SYDNEY
Award Amount
$2,091,723.00
Ceiling
$2,091,723.00
Awarded
September 30, 2022
Identifier
75N93022C00041-P00004-9999-1
Research project awarded to advance vaccine adjuvant research for tuberculosis, focusing on evaluation in animal models to develop preventive TB vaccines.
Description
This project involves research on vaccine adjuvants for tuberculosis, including evaluation of adjuvants in mouse and non-human primate models, with a focus on developing preventive TB vaccines.